FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its